A leading pharmaceutical company wanted to identify the potential for its IBR vaccines in Europe and assess the challenges it would face during product launch.
The client wanted to quantify the potential for its new product at a European level and analyze the critical challenges that it may encounter when launching the vaccine.
We conducted extensive primary and secondary research to determine the market size, trends, and key competitors’ products. We also critically analyzed the regulatory compliance requirements that could pose a potential challenge during product launch.
The client gained a better understanding of the market and aligned its go-to-market strategies accordingly. It was also able to restructure its product launch strategies in alignment with the regulations and compliance requirements of different target countries.